Showing results (11-20 of 18) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Head & Neck|October 2, 2004
Usefulness of fluorine-18 fluorodeoxyglucose positron emission tomography in patients with a residual structural abnormality after definitive treatment for squamous cell carcinoma of the head and neckRobert E Ware, Jane P Matthews, Rodney J Hicks, et al.European Urology Open Science|December 25, 2024
High Detection Rates for Prostate-specific Membrane Antigen-avid Prostate Cancer Recurrence at Low Prostate-specific Antigen levels on Extended Axial Field-of-view Positron Emission Tomography/Computed TomographySarah Thomas, Jason Callahan, Paul Conway, et al.Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|December 17, 2009
Comparative PET study using F-18 FET and F-18 FDG for the evaluation of patients with suspected brain tumourEddie W F Lau, Katharine J Drummond, Robert E Ware, et al.Cancer|November 30, 2006
How do oncologists deal with incidental abnormalities on whole-body fluorine-18 fluorodeoxyglucose PET/CT?Guohui Wang, Eddie W F Lau, Ramdave Shakher, et al.The Heart Surgery Forum|August 21, 2003
Review of efforts to decrease costly leg wound complications in the medicare population following coronary revascularizationC Phillip Brandt, G Clark Greene, Thomas R Pollard, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 17, 2013
18F-flumazenil: a γ-aminobutyric acid A-specific PET radiotracer for the localization of drug-resistant temporal lobe epilepsyLucy Vivash, Marie-Claude Gregoire, Eddie W Lau, et al.Molecular Imaging and Biology|June 19, 2025
Poor Diagnostic Performance of the Melanin-Binding Tracer [18 F]MEL050 in Human Melanoma Indicates Biological HeterogeneityRobert E Ware, Damien Kee, Peter Roselt, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 17, 2018
<sup>64</sup>Cu-SARTATE PET Imaging of Patients with Neuroendocrine Tumors Demonstrates High Tumor Uptake and Retention, Potentially Allowing Prospective Dosimetry for Peptide Receptor Radionuclide TherapyRodney J Hicks, Price Jackson, Grace Kong, et al.Pageof 2